The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes
posted on 2020-08-27, 11:48authored byKristina S. Boye, Hélène Sapin, Luis-Emilio García-Pérez, Myriam Rosilio, Marco Orsini Federici, Elke Heitmann, Heike Jung, Ulrich Aigner, Bruno Guerci, Francesco Giorgino, Kirsi Norrbacka
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).